New diabetes clinical trial: The Effects of a GRA on Non-Glucose Metabolic Pathways in Patients With Type 1 Diabetes (Pilot Study)

Published on: April 18, 2019 at 07:00PM
Condition:   Type 1 Diabetes Mellitus
Intervention:   Drug: REMD-477
Sponsors:   University of California, San Diego;   REMD Biotherapeutics, Inc.
Not yet recruiting